Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
US Army
Harvard Business School
Teva
Healthtrust
Johnson and Johnson
Merck
Cerilliant
US Department of Justice

Generated: May 22, 2018

DrugPatentWatch Database Preview

VENOFER Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Venofer patents expire, and what generic alternatives are available?

Venofer is a drug marketed by Luitpold and is included in one NDA.

The generic ingredient in VENOFER is iron sucrose. There are seventy-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iron sucrose profile page.
Summary for VENOFER
Drug patent expirations by year for VENOFER
Pharmacology for VENOFER

US Patents and Regulatory Information for VENOFER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-002 Mar 20, 2005 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-001 Nov 6, 2000 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-005 Mar 29, 2013 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VENOFER iron sucrose INJECTABLE;INTRAVENOUS 021135-003 Mar 29, 2005 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Federal Trade Commission
Harvard Business School
Dow
Moodys
Farmers Insurance
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.